Literature DB >> 16633768

Effects of lumbar sympathetic ganglion block for a patient with amyotrophic lateral sclerosis (ALS).

Takeshi Kitoh1, Koichi Kobayashi, Hiroaki Ina, Yukihiro Ofusa, Tetsutaro Otagiri, Satoshi Tanaka, Koichi Ono.   

Abstract

A 59-year-old man with amyotrophic lateral sclerosis (ALS) received lumbar epidural and sympathetic ganglion blocks to increase regional blood flow and improve his clinical symptoms. After a lumbar epidural block (0.5% mepivacaine), the skin temperature of his affected lower extremities rose by 7.0 degrees C and became close to that of the intact side, and the distance he was able to walk with his cane increased from 2 to 8 m. The clinical effects produced by the lumbar sympathetic ganglion block (99.5% alcohol) were sustained for approximately 8 weeks after the first block and for approximately 6 weeks after the second block. There were no particular adverse effects or complications associated with these nerve block procedures. Epidural and sympathetic ganglion blocks for an ALS patient, albeit their effects are of a transient nature, may improve related clinical symptoms, and were thought to play a contributory role in improving our patient's quality of life.

Entities:  

Mesh:

Year:  2006        PMID: 16633768     DOI: 10.1007/s00540-005-0375-4

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  8 in total

1.  [Anesthetic management of a patient with amyotrophic lateral sclerosis].

Authors:  H Mashio; Y Ito; Y Yanagita; E Fujisawa; K Hada; Y Goda; H Kawahigashi
Journal:  Masui       Date:  2000-02

2.  Therapeutic developments in amyotrophic lateral sclerosis.

Authors:  E C Lai
Journal:  Expert Opin Investig Drugs       Date:  1999-04       Impact factor: 6.206

3.  Treatment of muscular atrophy by regional nerve block.

Authors:  Y Terauchi
Journal:  Lancet       Date:  1976-08-28       Impact factor: 79.321

4.  Increased sympathetic outflow to muscles in patients with amyotrophic lateral sclerosis: a comparison with other neuromuscular patients.

Authors:  K Shindo; S Tsunoda; Z Shiozawa
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

5.  [Anesthetic management of two patients with amyotrophic lateral sclerosis (ALS)].

Authors:  Naomi Otsuka; Motohiko Igarashi; Yuuki Shimodate; Kenichi Nakabayashi; Makoto Asano; Akiyoshi Namiki
Journal:  Masui       Date:  2004-11

6.  Amyotrophic lateral sclerosis severity scale.

Authors:  A D Hillel; R M Miller; K Yorkston; E McDonald; F H Norris; N Konikow
Journal:  Neuroepidemiology       Date:  1989       Impact factor: 3.282

7.  [Skin sympathetic nerve activity in amyotrophic lateral sclerosis].

Authors:  K Yamamoto; G Sobue; S Iwase; T Mitsuma; T Mano
Journal:  Rinsho Shinkeigaku       Date:  1994-04

8.  Chronological changes of sympathetic outflow to muscles in amyotrophic lateral sclerosis.

Authors:  Kazumasa Shindo; Chikashi Shimokawa; Harue Watanabe; Haruyasu Iida; Kenji Ohashi; Kiyoaki Nitta; Takamura Nagasaka; Shin-Ichi Tsunoda; Zenji Shiozawa
Journal:  J Neurol Sci       Date:  2004-12-15       Impact factor: 3.181

  8 in total
  2 in total

1.  Peripheral nerve block in a patient with amyotrophic lateral sclerosis.

Authors:  Nezih Sertöz; Semra Karaman
Journal:  J Anesth       Date:  2011-11-01       Impact factor: 2.078

2.  Comment on "Anaesthetic management of a patient with amyotrophic lateral sclerosis for transurethral resection of bladder tumour".

Authors:  Adriano Bs Hobaika; Artur Palhares Neto
Journal:  Indian J Anaesth       Date:  2013-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.